ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO

Hypertension

Volumn 40, Issue 3, 2002, Pages 329-334

  Shiuchi, Tetsuya ^a   Cui, Tai Xing ^a   Wu, Lan ^a   Nakagami, Hironori ^a   Takeda Matsubara, Yuko ^a   Iwai, Masaru ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; Bradykinin; Glucose; Insulin resistance; Nitric oxide

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; DEOXYGLUCOSE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUCOSE TRANSPORTER 4; ICATIBANT; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TEMOCAPRIL; TEMOCAPRILAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; INSULIN RESISTANCE; MALE; MEMBRANE TRANSPORT; MOUSE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BRADYKININ; CELL LINE; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; KINETICS; MALE; MICE; MICE, INBRED C57BL; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; NITRIC OXIDE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN TRANSPORT; THIAZEPINES;

EID: 0036711810     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000028979.98877.0C     Document Type: Article

References (34)

1. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
2. Applications of NMR spectroscopy to study muscle glycogen metabolism in man
3. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
4. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus
5. Glucose transport and NIDDM
6. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM
7. Captopril does not acutely enhance insulin sensitivity
8. Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin resistant Japanese patients with essential hypertension
9. Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients
10. Captopril does not improve insulin action in essential hypertension: A double-blind placebo-controlled study
11. ACE inhibition and glucose transport in insulin-resistant muscle: Roles of bradykinin and nitric oxide
12. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats
13. Glucose transport activity in insulin-resistant rat muscle: Effect of angiotensin-converting enzyme inhibitors and bradykinin antagonism
14. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans
15. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity
16. ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients
17. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat
18. Effect of captopril, losartan, and bradykinin on early steps of insulin action
19. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension
20. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS)
21. Bradykinin directly triggers GLUT4 translocation via an insulinindependent pathway
22. Nitric oxide in skeletal muscle
23. Expression of nitric oxide synthase in skeletal muscle: A pivotal role for nitric oxide as a modulator of insulin action
24. Receptor-regulated translocation of endothelial nitric-oxide synthase
25. Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle
26. Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-AY mice
27. Ventromedial hypothalamus stimulation enhances peripheral glucose uptake in anesthetized rats
28. Effect of angiotensin converting enzyme inhibitors on glucose uptake
29. Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus
30. Divergent regulation of Aktl and Akt2 isoforms I insulin target tissue of obese Zucker rats
31. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels: A potential role for serine phosphorylation in insulin/angiotensin II crosstalk
32. Production of angiotensin II receptors type one (AT1) and type two (AT2) during the differentiation of 3T3-L1 preadipocytes
33. The tissue renin-angiotensin system in rats with fructose-induced hypertension: Overexpression of type 1 angiotensin II receptor in adipose tissue
34. Co-expression of renin-angiotensin system genes in human adipose tissue